Relapsed multiple myeloma
Clinical trials for Relapsed multiple myeloma explained in plain language.
Never miss a new study
Get alerted when new Relapsed multiple myeloma trials appear
Sign up with your email to follow new studies for Relapsed multiple myeloma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an antibody drug boost transplant results in relapsed myeloma?
Disease control OngoingResearchers are testing whether adding the antibody drug isatuximab to dexamethasone before and after an autologous stem cell transplant helps patients with relapsed multiple myeloma. About 50 adults who already had a transplant and later relapsed will receive three cycles of isa…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase 2 • Sponsor: EMN Trial Office S.r.l. Impresa Sociale • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New Three-Drug cocktail targets Hard-to-Treat myeloma
Disease control OngoingThis study tests a new combination of three drugs—belantamab mafodotin, carfilzomib, and dexamethasone—in people whose multiple myeloma has returned and is no longer responding to lenalidomide. The trial has two parts: first, finding the safest dose, then testing that dose in up …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase 1/2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Experimental CAR-T therapy takes on Hard-to-Treat myeloma
Disease control OngoingThis early-phase trial is testing a new type of immune cell therapy called Anti-BCMA CAR-T cells in 5 adults with multiple myeloma that has come back or not responded to at least three prior treatments. The therapy involves collecting a patient's own immune cells, modifying them …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase 1 • Sponsor: Thomas Martin, MD • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug RO7875913 tested in healthy volunteers for first time
Knowledge-focused OngoingThis early-stage trial is testing a new drug called RO7875913 in 40 healthy volunteers to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo. The study aims to find the right dose for future trials, but offers no direct treatme…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase 1 • Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC